Results

eNauka >  Results >  Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL)
Title: Phase Ib study combining ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in patients with CD20-positive B-cell non-Hodgkin lymphoma (NHL)
Authors: Younes, Anas; ...; Todorovic, Marija; ...; (broj, koautora 16)
Issue Date: 2013
Publication: JOURNAL OF CLINICAL ONCOLOGY
ISSN: 0732-183X Journal of Clinical Oncology Search Idenfier
Type: Conference Paper
Collation: vol. 31 br. 15
WoS-ID: 000335419602598
URI: https://enauka.gov.rs/handle/123456789/808545
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

3
WEB OF SCIENCETM

Find the DOI


Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.